Robotic Biopsy Devices Market Size, Share Global Analysis Report, 2019 – 2026

Industry Insights

[225+ Pages Report] According to the report published by Facts Factors, the global robotic biopsy devices market size was worth around USD 300 million in 2019 and is predicted to grow to around USD 700 million by 2026 with a compound annual growth rate (CAGR) of roughly 13% between 2020 and 2026. The report analyzes the global robotic biopsy device market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the robotic biopsy devices market.

This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the robotic biopsy devices industry. The report analyzes and declares the historical and current trends analysis of the robotic biopsy devices industry and subsequently recommends the projected trends anticipated to be observed in the robotic biopsy devices market during the upcoming years.

Key Insights from Primary Research

• As per our primary respondents, the global robotic biopsy devices market is set to grow annually at a rate of around 13%.
• It was established through primary research that the global robotic biopsy devices market was valued at around USD 300 Million in 2019.
• The “instruments and accessories” category, on the basis of product type segmentation, was the leading revenue-generating category in 2019.
• On the basis of application segmentation, the “Lung biopsy” category was the leading revenue-generating category in 2019.
• Based on the region, North America was the leading revenue-generating category in 2019.

Key Recommendations from Analysts

• As per our analysis, the global robotic biopsy devices market is growing at a high CAGR and various end-use industries are aware of this potential market and applications of robotic biopsy devices.
• Growing at a CAGR of around 13%, the global robotic biopsy devices market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
• Our analysts have identified instruments and accessories and Lung biopsy providers segments that will be dominating for global robotic biopsy devices market in terms of product type and application segmentation respectively.
• As per our analysis, North America is expected to account for the maximum revenue share, in the target market.

The robotic biopsy devices market report analyzes and notifies the industry statistics at the global, regional, and country levels to acquire a thorough perspective of the entire robotic biopsy devices market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in value (USD 700 Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the robotic biopsy devices industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the robotic biopsy devices industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the robotic biopsy devices market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the robotic biopsy devices industry. The robotic biopsy devices market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the robotic biopsy devices sector. Key strategic developments in the robotic biopsy devices market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the robotic biopsy devices market are appropriately highlighted in the report.

Report Scope

The interest in automated biopsy gadgets showcase is driven by the expanding predominance of malignant growth and the developing inclination for negligibly obtrusive surgeries. Furthermore, expanding mindfulness, ideal repayment arrangements, and expanding medicinal services spending are significant elements that support market development. However, the absence of talented experts and the significant expense of the method may confine the market development over the conjecture time frame. Developing markets are relied upon to fill in as development opens doors for worldwide automated biopsy gadgets market players.

Expanding disease commonness, good repayment approaches, expanding reception of negligibly obtrusive surgeries and accessibility of cutting-edge well-being offices are factors that help the market development. Quick appropriation of mechanically propelled instruments, developing old populace, expanding disease predominance, and expanding mindfulness are key factors that fuel the market development right now. The high development is credited to rising mindfulness and quick reception of insignificantly intrusive robots helped careful biopsy strategies, expanding well-being going through alongside developing disease predominance, and expanding maturing populace are factors advancing mechanical biopsy gadgets showcase development.

The market for robotic biopsy device gadgets is disseminated based on product type, application, and region. In light of product type, the market is bifurcated into the system, instruments, and accessories. In 2019, the worldwide mechanical biopsy gadgets market was ruled by the instruments and accessories type portion with an income portion of practically 60%. This enormous offer is licensed to the accessibility of the huge scope of instruments for biopsy and accessories. Developing malignant growth predominance and expanding ventures by end clients to offer better patient consideration are assessed to additionally help the market development of this fragment

In light of application, the market is sectioned into prostate biopsy, lung biopsy, mind biopsy, and other applications. Lung biopsy is the most pervasive malignant growth type and the driving reason for mortality. The lung malignant growth application section held the biggest piece of the pie in 2019. Developing lung disease commonness alongside ascend in smoking, changing ecological conditions, expanding air contamination levels, and expanding mindfulness are different elements that are relied upon to help the market development of lung malignant growth application section

Some of the essential players operating in the market

•  Renishawplc
•  Medtronic
•  Medtech SA
•  Medrobotics
•  Mazor Robotics
•  iSYSMedizintechnik GmbH
•  Biobot Surgical Pte Ltd.

The taxonomy of the robotic biopsy devices Market by its scope and segmentation is as follows:

By Product Type

• System
• Instruments and Accessories

By Application

• Lung Biopsy
• Prostate Biopsy
• Brain Biopsy
• Other Applications

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• The Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa